SEC 13F Intelligence

Spotlight Asset Group, Inc. / TGTX

Spotlight Asset Group, Inc.’s Tg Therapeutics Inc Position

Does Spotlight Asset Group, Inc. own Tg Therapeutics Inc (TGTX)? Yes — 82.1K shares worth $1M (+1.02% of its 13F portfolio) as of Q2 2024.

Position Value
$1M
Q2 2024
Shares
82.1K
% of Portfolio
+1.02%
Quarters Held
14
currently held

Position History TGTX

Reported value by quarter
Q1 ’20: $541,000Q1 ’20Q2 ’20: $1MQ3 ’20: $1MQ3 ’20Q4 ’20: $3MQ1 ’21: $4MQ1 ’21Q2 ’21: $3MQ3 ’21: $2MQ3 ’21Q3 ’22: $391,000Q1 ’23: $391,000Q1 ’23Q2 ’23: $2MQ3 ’23: $660,440Q3 ’23Q4 ’23: $660,440Q1 ’24: $1MQ1 ’24Q2 ’24: $1Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 202482.1K$1M+1.02%
Q1 202482.1K$1M+0.89%
Q4 202379.0K$660,440+0.60%
Q3 202379.0K$660,440+0.60%
Q2 202375.0K$2M+1.67%
Q1 202375.0K$391,000+0.39%
Q3 202275.0K$391,000+0.39%
Q3 202175.0K$2M+1.24%
Q2 202175.0K$3M+1.12%
Q1 202175.0K$4M+1.36%
Q4 202055.0K$3M+1.06%
Q3 202055.0K$1M+0.58%
Q2 202055.0K$1M+0.45%
Q1 202055.0K$541,000+0.29%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Spotlight Asset Group, Inc.’s full portfolio or all institutional holders of TGTX.